Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Resminostat

EU orphan designation number: EU/3/11/930   
Active ingredient: Resminostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: 4SC AG
Am Klopferspitz 19a, D-82152 Martinsried, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Centralised Orphan - Designation EMA/OD/083/11 (2011)9415 of 09/12/2011